CGON
Price
$54.18
Change
+$12.25 (+29.22%)
Updated
Jan 9, 04:59 PM (EDT)
Capitalization
3.38B
76 days until earnings call
Intraday BUY SELL Signals
CLDX
Price
$27.37
Change
+$0.02 (+0.07%)
Updated
Jan 9, 04:59 PM (EDT)
Capitalization
1.82B
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGON vs CLDX

Header iconCGON vs CLDX Comparison
Open Charts CGON vs CLDXBanner chart's image
CG Oncology
Price$54.18
Change+$12.25 (+29.22%)
Volume$29.52K
Capitalization3.38B
Celldex Therapeutics
Price$27.37
Change+$0.02 (+0.07%)
Volume$14.85K
Capitalization1.82B
CGON vs CLDX Comparison Chart in %
View a ticker or compare two or three
VS
CGON vs. CLDX commentary
Jan 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a StrongBuy and CLDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 10, 2026
Stock price -- (CGON: $41.93 vs. CLDX: $27.35)
Brand notoriety: CGON and CLDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 144% vs. CLDX: 96%
Market capitalization -- CGON: $3.38B vs. CLDX: $1.82B
CGON [@Biotechnology] is valued at $3.38B. CLDX’s [@Biotechnology] market capitalization is $1.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.17B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileCLDX’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • CLDX’s FA Score: 0 green, 5 red.
According to our system of comparison, CGON is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 7 TA indicator(s) are bullish while CLDX’s TA Score has 6 bullish TA indicator(s).

  • CGON’s TA Score: 7 bullish, 3 bearish.
  • CLDX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, CGON is a better buy in the short-term than CLDX.

Price Growth

CGON (@Biotechnology) experienced а +0.99% price change this week, while CLDX (@Biotechnology) price change was +0.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.49%. For the same industry, the average monthly price growth was -0.45%, and the average quarterly price growth was +47.36%.

Reported Earning Dates

CGON is expected to report earnings on Mar 27, 2026.

CLDX is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+3.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($3.38B) has a higher market cap than CLDX($1.82B). CGON YTD gains are higher at: 0.987 vs. CLDX (0.700). CGON has higher annual earnings (EBITDA): -179.53M vs. CLDX (-252.86M). CGON has more cash in the bank: 680M vs. CLDX (583M). CLDX has less debt than CGON: CLDX (2.62M) vs CGON (7.24M). CLDX has higher revenues than CGON: CLDX (2.6M) vs CGON (2.17M).
CGONCLDXCGON / CLDX
Capitalization3.38B1.82B186%
EBITDA-179.53M-252.86M71%
Gain YTD0.9870.700141%
P/E RatioN/AN/A-
Revenue2.17M2.6M84%
Total Cash680M583M117%
Total Debt7.24M2.62M276%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONCLDX
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 24 days ago
80%
Bearish Trend 5 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signal:
Gain/Loss:
CLDX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSEQX46.670.71
+1.54%
JPMorgan Small Cap Equity R4
WDIIX15.070.13
+0.87%
Wilmington Enhanced Div Inc Strat I
CFMCX12.310.06
+0.49%
Column Mid Cap
FRISX91.500.15
+0.16%
Franklin Rising Dividends R6
PUVCX43.92-0.03
-0.07%
Putnam International Small Cap C

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-1.22%
SYRE - CGON
56%
Loosely correlated
-2.93%
NUVL - CGON
55%
Loosely correlated
-3.89%
XNCR - CGON
55%
Loosely correlated
-5.08%
IDYA - CGON
55%
Loosely correlated
-3.78%
CLDX - CGON
54%
Loosely correlated
-1.48%
More

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-1.48%
BEAM - CLDX
56%
Loosely correlated
-3.21%
XNCR - CLDX
55%
Loosely correlated
-5.08%
KURA - CLDX
55%
Loosely correlated
-4.21%
VRDN - CLDX
54%
Loosely correlated
-0.79%
CGON - CLDX
54%
Loosely correlated
-1.22%
More